Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
桥粒芯糖蛋白 1 在角质细胞-黑色素细胞通讯和黑色素瘤中的作用
基本信息
- 批准号:10337049
- 负责人:
- 金额:$ 38.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAbnormal KeratinocyteAffectAnimal ModelAntioxidantsAttenuatedBehaviorBindingBiological MarkersCadherinsCell Adhesion MoleculesCell-Cell AdhesionCellsChronicClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesCommunicationDataDevelopmentDown-RegulationDysplastic NevusERBB2 geneEpidermisExhibitsFeedbackGeneticHistologicHomeostasisHumanHuman PathologyIndividualKnowledgeLesionMalignant - descriptorMalignant NeoplasmsMelanocytic nevusMelanogenesisMelanoma CellModelingMovementN-CadherinParacrine CommunicationPigmentsPlayProductionProphylactic treatmentProteinsResearchRoleSignal TransductionSkin CancerSkin CarcinomaSkin tanningStratum BasaleSun ExposureTestingUV Radiation ExposureUV responseUltraviolet Raysbiological adaptation to stresscell typecytokinedesmoglein 1driver mutationhigh riskhuman modelhuman tissuekeratinocytemelanocytemelanomamelanomagenesismouse modelmutantnovelparacrineperoxiredoxin Iresponsescaffoldtherapeutic targetthree-dimensional modelingtumor microenvironmenttumorigenicultraviolet
项目摘要
Project Summary/Abstract
Melanoma arises from transformation of melanocytes (MCs) in the basal layer of the epidermis where they are
surrounded by keratinocytes (KCs). While research has focused predominantly on identifying driver mutations
involved in conversion of MCs to melanoma, histologically normal fields of abnormal KCs are also present in
sun-exposed epidermis in which melanomas arise. The extent to which melanoma is promoted by altered KCs
that surround early lesions is unknown. Our long-term objectives are to define how altered KC:MC
communication drives melanoma development and to identify alterations in KCs surrounding pigmented nevi
that serve as predictors of malignant transformation and as therapeutic targets. KC:MC interactions occur
directly through cadherins and indirectly through secreted factors. Alterations in classic cadherin expression
are known to affect melanoma initiation and progression, but little is known about desmosomal cadherins' roles
in melanoma. Our data support the idea that the desmosomal cadherin, desmoglein 1 (Dsg1), is critical for MC
homeostasis even though it is expressed only in neighboring KCs. Loss of Dsg1 stimulates the production of
KC cytokines and other secreted factors that increase MC number, dendricity, pigment production, and pro-
tumorigenic cytokine expression. These features resemble the MC response to ultraviolet (UV) light, and we
showed that UV results in selective loss of KC Dsg1. Our data also show that Dsg1 is suppressed by secreted
factors from melanoma cells, and its expression is decreased in peri-lesional nests surrounding human
melanomas and dysplastic nevi. This suggests the existence of a feedback loop that stabilizes a Dsg1-deficient
pro-melanomagenic KC:MC unit within the tumor microenvironment. We propose that Dsg1's loss following UV
exposure contributes to MC responses to UV, but that chronic damage and prolonged suppression of Dsg1
promotes melanoma development through coordination of pro-tumorigenic paracrine signaling and altered
KC:MC contact. We will use candidate and unbiased analysis of Dsg1-deficient 2/3D human models, human
tissues and a novel CRISPR/Cas Dsg1-deficient mouse model in conjunction with an HGF animal model of
melanoma that closely resembles human pathology to: 1) Determine how Dsg1 loss alters the KC secretome
and stimulates MC behaviors resembling the UV response through cooperative paracrine and cell contact-
dependent signaling and 2) Determine how a sustained Dsg1-deficient KC:MC unit is established to promote
malignant transformation and melanoma development. Understanding KC:MC communication will provide the
basis for development of new biomarkers to identify individuals at high risk of developing malignant melanoma,
and who may be candidates for prophylactic treatment with agents that restore normal KC:MC communication.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen Janee Green其他文献
Kathleen Janee Green的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen Janee Green', 18)}}的其他基金
Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
桥粒芯糖蛋白 1 在角质细胞-黑色素细胞通讯和黑色素瘤中的作用
- 批准号:
10092121 - 财政年份:2019
- 资助金额:
$ 38.62万 - 项目类别:
Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
桥粒芯糖蛋白 1 在角质细胞-黑色素细胞通讯和黑色素瘤中的作用
- 批准号:
10558743 - 财政年份:2019
- 资助金额:
$ 38.62万 - 项目类别:
Function of Desmoglein 1/Pemphigus Foliaceus Antigen
桥粒芯糖蛋白 1/天疱疮叶状疱疹抗原的功能
- 批准号:
7809799 - 财政年份:2009
- 资助金额:
$ 38.62万 - 项目类别:
Regulation of Desmosomal Cadherins in Oral Cancer
口腔癌中桥粒钙粘蛋白的调节
- 批准号:
7805576 - 财政年份:2006
- 资助金额:
$ 38.62万 - 项目类别:
Regulation of Desmosomal Cadherins in Oral Cancer
口腔癌中桥粒钙粘蛋白的调节
- 批准号:
7129708 - 财政年份:2006
- 资助金额:
$ 38.62万 - 项目类别:
Regulation of Desmosomal Cadherins in Oral Cancer
口腔癌中桥粒钙粘蛋白的调节
- 批准号:
7619471 - 财政年份:2006
- 资助金额:
$ 38.62万 - 项目类别:














{{item.name}}会员




